Physician profile
Mona Ehasz
NPI 1497001986
$7,393.64
in general payments reported to CMS, 2019-2025
12 companies · $772 in 2025
The $772 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.07 · 2021: $103 · 2022: $2,394 · 2023: $1,061 · 2024: $2,965 · 2025: $772.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,065 · Travel and Lodging: $732.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,065.45 |
| Travel and Lodging | $732.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,957.89 | 2022-2025 | Intellis Adaptivestim, Accurian, Synchromedii |
| Nevro Corp. | $1,339.46 | 2022-2024 | Senza |
| Spinal Simplicity, LLC | $732.12 | 2024 | Ha Minuteman G3-R |
| Vertos Medical, INC. | $706.20 | 2022-2024 | Mild Device Kit |
| Nalu Medical, INC. | $505.99 | 2023-2024 | Nalu Neurostimulation System |
| Globus Medical, INC. | $364.50 | 2025 | Senza, Vyrsa Fix |
| Abbott Laboratories | $291.13 | 2021-2024 | Proclaim |
| Foundation Fusion Solutions, LLC | $130.89 | 2025 | |
| Zavation Medical Products, LLC | $106.67 | 2025 | |
| Revance Therapeutics, INC. | $101.05 | 2024 | Daxxify |
| Merck Sharp & Dohme LLC | $99.07 | 2019 | |
| Stryker Corporation | $58.67 | 2025 | 1788 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mona Ehasz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.